Verbio (VBK) German Select VII Conference summary
Event summary combining transcript, slides, and related documents.
German Select VII Conference summary
15 Apr, 2026Company performance and milestones
Achieved 12 TWh of bioenergy production and 4.5–5.5 million tons of CO2 savings in the last financial year, with full capacity utilization in Germany and ongoing ramp-up in North America and India.
Production volumes increased due to operational efficiency and international expansion, with FY 2024/25 output at 619.3 kt biodiesel, 582.6 kt bioethanol, and 1,190.3 GWh biomethane.
EBITDA declined from €503.3m in 2021/22 to €14.2m in 2024/25, with net income at -€137.9m and net cash at -€164.0m, but recovery began in H1 2025/26 with EUR 45.5 million EBITDA.
Return on capital employed remained above 20% through cycles until recent disruptions, dropping to -11.9% in 2024/25.
International diversification is progressing, with two U.S. plants expected to balance production volumes between Europe and America.
Business model and competitive advantages
Utilizes local agricultural biomass and residues in proprietary biorefineries, producing biodiesel, ethanol, renewable natural gas, and co-products like glycerine, sterols, and fertilizer.
Unique process allows simultaneous production of bioethanol and biomethane, enhancing circularity and value extraction from diverse feedstocks.
Competitive edge comes from feedstock cost advantage, operational efficiency, CO2 savings, and market optimization by targeting highest-value markets globally.
Proprietary conversion technologies and co-product capture drive operational efficiency and margin resilience.
Listed on the Frankfurt Stock Exchange with a market cap of EUR 2.37 million as of April 2026.
Market trends and regulatory environment
Recent regulatory changes in Germany and the EU removed double counting, introduced stricter controls, and raised GHG savings mandates, benefiting crop-based and advanced fuels.
Policy changes are expected to double the CO2 savings mandate in coming years, supporting market growth and reducing fraudulent supply.
Faced market disruption in Germany due to fraudulent biofuel inflows and weak verification, impacting GHG quota prices and EBITDA.
Global policy momentum supports biofuels: tax credits in Canada, RED III in the EU, IRA in the US, and blending mandates in Asia.
Maritime and heavy-duty transport sectors are increasingly adopting biofuels, with BioLNG offering significant cost advantages and gaining traction.
Latest events from Verbio
- Revenue up 19% and EBITDA tripled, driven by higher production and GHG quota demand.VBK
Q2 25/2612 Apr 2026 - Record biofuel output and growth investments set stage for higher EBITDA in FY 2024/25.VBK
Q4 23/2420 Jan 2026 - EBITDA and revenue fell, but guidance and regulatory support remain positive for FY 2024/25.VBK
Q1 24/2514 Jan 2026 - EBITDA and revenue fell, but Q2 rebounded and guidance was cut amid market and technical headwinds.VBK
Q2 24/2516 Dec 2025 - EBITDA and revenue fell, but production hit records; guidance and CapEx were cut.VBK
Q3 24/2518 Nov 2025 - Revenue up 22%, EBITDA surged, and outlook for FY 2025/2026 remains strong.VBK
Q1 25/2612 Nov 2025 - EBITDA fell on weaker margins and impairment, but outlook is positive with rising global demand.VBK
Q4 24/2525 Sep 2025